104 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 3 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
IL12BInterleukin 12BDisease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Not detected
IL17AInterleukin 17ACancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IL1R1Interleukin 1 receptor type 1Cancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL23AInterleukin 23 subunit alphaFDA approved drug targets
Predicted secreted proteins
CytosolTissue enhanced
IL2RAInterleukin 2 receptor subunit alphaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
IL2RBInterleukin 2 receptor subunit betaCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL2RGInterleukin 2 receptor subunit gammaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
VesiclesTissue enhanced
IL3RAInterleukin 3 receptor subunit alphaCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
IL5Interleukin 5Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
IL6Interleukin 6Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
INSRInsulin receptorCD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
VesiclesExpressed in all
ITGA2BIntegrin subunit alpha 2bCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ITGA4Integrin subunit alpha 4Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneTissue enhanced
ITGALIntegrin subunit alpha LCD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGAVIntegrin subunit alpha VCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Focal adhesion sites
Cytosol
Expressed in all
ITGB1Integrin subunit beta 1Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Endoplasmic reticulum
Plasma membrane
Focal adhesion sites
Expressed in all
ITGB3Integrin subunit beta 3Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGB7Integrin subunit beta 7Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Mixed
KDRKinase insert domain receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
LEPRLeptin receptorCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
VesiclesMixed
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
M6PRMannose-6-phosphate receptor, cation dependentFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
MR1Major histocompatibility complex, class I-relatedFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneMixed
MS4A1Membrane spanning 4-domains A1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneGroup enriched
MS4A2Membrane spanning 4-domains A2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
PDCD1Programmed cell death 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
PDGFRBPlatelet derived growth factor receptor betaCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Golgi apparatus
Vesicles
Mixed
PGFPlacental growth factorCancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
RAS pathway related proteins
Nucleoplasm
Mitochondria
Cytosol
Tissue enhanced
PLATPlasminogen activator, tissue typeCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Actin filamentsTissue enriched
PLAUPlasminogen activator, urokinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
PLAURPlasminogen activator, urokinase receptorCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneExpressed in all
PLGPlasminogenCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enriched
PLIN3Perilipin 3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Lipid droplets
Cytosol
Expressed in all
PTH2RParathyroid hormone 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
RAMP1Receptor activity modifying protein 1FDA approved drug targets
Predicted membrane proteins
Nucleoplasm
Nuclear membrane
Tissue enhanced
RAMP2Receptor activity modifying protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesMixed
S1PR1Sphingosine-1-phosphate receptor 1Cancer-related genes
CD markers
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
VesiclesExpressed in all
SCTRSecretin receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
SERPINB2Serpin family B member 2Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Group enriched
SERPINC1Serpin family C member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPIND1Serpin family D member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enriched
SERPINE1Serpin family E member 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
CytosolTissue enhanced
SLAMF7SLAM family member 7CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesMixed
SNAP25Synaptosome associated protein 25Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Transporters
Tissue enriched
SYT2Synaptotagmin 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
VesiclesTissue enhanced
TLR2Toll like receptor 2CD markers
FDA approved drug targets
Predicted membrane proteins
Nucleus
Mitochondria
Tissue enhanced
TNFRSF8TNF receptor superfamily member 8Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
TNFSF11Tumor necrosis factor superfamily member 11Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
TNFSF13BTumor necrosis factor superfamily member 13bCancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
TSHRThyroid stimulating hormone receptorCancer-related genes
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
« prev | Page of 3 | next »